Condition: Healthy Newborn Infants · Sponsor: Turku University Hospital
The aim is to study whether the microbiota of children who are exposed to antibiotics at birth could be modified by synbiotic supplement and thereby reduce the risk of obesity, chronic diseases and respiratory tract infections. A total of 125 mother-child pairs will be recruited in this randomized, double-blind, placebo-controlled study. Infants are randomized to receive either a synbiotic supplement or a placebo for 2 months, after which their growth and morbidity will be monitored at the research clinic for 2 years.
This description comes directly from the study's public registry record.
Paula Tähtinen, MD, PhD · +358-2-3130746 · paula.tahtinen@utu.fi
Always discuss trial participation with your own doctor first.
| Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku | Turku, Valitse Maakunta., Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06974994